Eating Disorders Trial, Recruiting NCT07060534 Sponsor: University of Kansas Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT07060534
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older.
  • You must be a student currently enrolled at KU (Kansas University).
  • You must have been diagnosed with bulimia nervosa, binge-eating disorder, or a milder form of either condition (confirm with trial site).
  • You must have access to a smartphone.
  • You must not have any uncorrected vision problems that would get in the way of participating.
  • If you take any psychiatric or mood-related medications, you must have been on a stable dose for at least four weeks before joining.
  • You must be able to read and speak English fluently.

Who may not be able to join:

  • People who are currently having moderate or serious thoughts of suicide with an active intention to act on them.
  • People with significant mental health conditions that could interfere with the study, such as a current substance use disorder or psychosis.
  • People with certain medical conditions or taking certain medications that could interfere with the study, such as Type 1 diabetes, cancer, current pregnancy, breastfeeding, or use of corticosteroid medications.
  • People whose lab results show signs of medical instability, such as a very low heart rate, imbalanced electrolytes, or serious health complications from malnutrition, or any condition that means they cannot safely receive outpatient care (confirm with trial site).
  • People who are already receiving therapy for an eating disorder.
  • People who screen positive for anorexia nervosa, atypical anorexia nervosa, or who have a low body weight (BMI under 19.5), or who have avoidant/restrictive food intake disorder (ARFID).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kelsie Forbush, PhD, University of Kansas

Phone: 785-864-6525

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Kansas
Registry
ClinicalTrials.gov
Start date
23 June 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Binge eating and total number of eating disorder symptoms measured through the Eating Pathology Symptoms Inventory; BEST-U Daily Behavior Survey

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov